MARKETABLE SECURITIES (Details)	12 Months Ended
	Jul. 31, 2021 USD ($) shares
Available-for-sale Securities	$ 533,751
Available-for-sale Securities	10,436
Change in Fair Value of Marketable Securities	$ 523,315
Common Shares of Entest Group, Inc. (ENTI)
Investment Owned, Balance, Shares | shares	66,667
Available-for-sale Securities	$ 340
Available-for-sale Securities	260
Change in Fair Value of Marketable Securities	$ 80
Common Shares of Regen Biopharma, Inc. (RGBP)
Investment Owned, Balance, Shares | shares	29,076,665
Available-for-sale Securities	$ 393,989
Available-for-sale Securities	5,814
Change in Fair Value of Marketable Securities	$ 388,175
Series A Preferred Shares of Regen Biopharma, Inc. (RGBPP)
Investment Owned, Balance, Shares | shares	2,907,666
Available-for-sale Securities	$ 139,422
Available-for-sale Securities	4,362
Change in Fair Value of Marketable Securities	$ 135,060